DE60136356D1 - Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik - Google Patents

Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik

Info

Publication number
DE60136356D1
DE60136356D1 DE60136356T DE60136356T DE60136356D1 DE 60136356 D1 DE60136356 D1 DE 60136356D1 DE 60136356 T DE60136356 T DE 60136356T DE 60136356 T DE60136356 T DE 60136356T DE 60136356 D1 DE60136356 D1 DE 60136356D1
Authority
DE
Germany
Prior art keywords
vaccination
streptococcus
diagnosis
gapc protein
chimeric gapc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60136356T
Other languages
English (en)
Inventor
Andrew A Potter
Jose Perez-Casal
Michael Fontaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Original Assignee
University of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan filed Critical University of Saskatchewan
Application granted granted Critical
Publication of DE60136356D1 publication Critical patent/DE60136356D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60136356T 2000-06-12 2001-06-11 Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik Expired - Lifetime DE60136356D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21124700P 2000-06-12 2000-06-12
PCT/CA2001/000836 WO2001096379A2 (en) 2000-06-12 2001-06-11 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection

Publications (1)

Publication Number Publication Date
DE60136356D1 true DE60136356D1 (de) 2008-12-11

Family

ID=22786123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136356T Expired - Lifetime DE60136356D1 (de) 2000-06-12 2001-06-11 Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik

Country Status (12)

Country Link
US (4) US6660270B2 (de)
EP (1) EP1294771B1 (de)
AR (1) AR028713A1 (de)
AT (1) ATE412673T1 (de)
CA (1) CA2411919C (de)
CY (1) CY1108724T1 (de)
DE (1) DE60136356D1 (de)
DK (1) DK1294771T3 (de)
ES (1) ES2316450T3 (de)
PT (1) PT1294771E (de)
UY (1) UY26763A1 (de)
WO (1) WO2001096379A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833134B2 (en) * 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
WO2004018683A1 (en) * 2002-08-12 2004-03-04 Akzo Nobel N.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
US20070048096A1 (en) * 2004-12-07 2007-03-01 Hubbs Jonathan W Soil conditioner
US20060118009A1 (en) * 2004-12-07 2006-06-08 Hubbs Jonathan W Soil conditioner
US9216212B2 (en) 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US8012730B1 (en) * 2006-08-29 2011-09-06 The United States Of America As Represented By The Secretary Of Agriculture Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin
EP2023143A1 (de) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogene Streptokokkus-Proteine
US20100088957A1 (en) * 2008-10-09 2010-04-15 Hubbs Jonathan W Natural turf with binder
US8147849B2 (en) * 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains
US20100216639A1 (en) * 2009-02-20 2010-08-26 Hubbs Jonathon W Gypsum soil conditioner

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US4954618A (en) 1986-02-14 1990-09-04 Genex Corporation Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
US5198215A (en) * 1987-06-22 1993-03-30 Noordzee Laboratorium N.V. Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
US4977082A (en) 1987-12-10 1990-12-11 University Of Florida Research Foundation, Inc. Type VI bacterial FC receptors
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5237050A (en) 1989-03-29 1993-08-17 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
EP0672123A1 (de) * 1992-01-08 1995-09-20 The Rockefeller University Multifunktionale Oberflächeprotein von Streptokokken
WO1994006421A1 (en) * 1992-09-16 1994-03-31 The University Of Tennessee Research Corporation Recombinant multivalent m protein vaccine
EA199800046A1 (ru) * 1995-06-07 1998-06-25 Байокем Вэксинс Инк. Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
US5863543A (en) 1996-06-05 1999-01-26 University Of Saskatchewan Camp factor of streptococcus uberis
CN1226414C (zh) 1995-06-08 2005-11-09 萨斯喀彻温大学 乳房链球菌的camp因子
EP0905140B9 (de) * 1996-03-29 2009-05-13 Zeon Corporation Neues fusionsprotein, dafuer kodierendes gen, rekombinanter vektor, rekombinantes virus und dessen verwendung
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
US6485904B1 (en) * 1997-06-23 2002-11-26 Pfizer, Inc. DNA encoding a plasminogen activating protein
KR100771148B1 (ko) 1998-02-20 2007-10-29 아이디 바이오메디칼 코포레이션 그룹 ｂ 스트렙토코커스 항원
CA2356836C (en) 1998-12-23 2011-09-13 Shire Biochem Inc. Novel streptococcus antigens
US6391316B1 (en) * 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use

Also Published As

Publication number Publication date
ATE412673T1 (de) 2008-11-15
WO2001096379A3 (en) 2002-08-08
EP1294771A2 (de) 2003-03-26
PT1294771E (pt) 2009-01-06
CY1108724T1 (el) 2014-04-09
US20080009022A1 (en) 2008-01-10
WO2001096379A2 (en) 2001-12-20
UY26763A1 (es) 2001-08-27
US6660270B2 (en) 2003-12-09
US20040062774A1 (en) 2004-04-01
CA2411919A1 (en) 2001-12-20
EP1294771B1 (de) 2008-10-29
CA2411919C (en) 2012-07-31
US20020044928A1 (en) 2002-04-18
ES2316450T3 (es) 2009-04-16
US20050142615A1 (en) 2005-06-30
DK1294771T3 (da) 2008-12-15
US7258992B2 (en) 2007-08-21
US6875853B2 (en) 2005-04-05
AR028713A1 (es) 2003-05-21

Similar Documents

Publication Publication Date Title
IL228034A0 (en) Formulations with a high concentration of antibodies and proteins
ATA159499A (de) Einrichtung zur in vivo-messung von grössen in lebenden organismen
DE60238281D1 (de) Gerät zur aufzeichnung biologischer informationen und biologische informationen benutzendes berechtigungsgerät
IL172507A0 (en) New biological entities and the pharmaceutical or diagnostic use thereof
DE60207183D1 (de) Vorrichtung zur Beobachtung biologischer Daten
DE60122783D1 (de) Endoskopische vorrichtung zur bewegung durch den gastrointestinaltrakt
DE10192291D2 (de) Lagerungshilfe zur tomographischen Funktionsuntersuchung der Halswirbelsäule
EP1575992A4 (de) Chimäre proteine aus proteintransduzierender domäne/deaminase, verwandte verbindungen und deren verwendungen
NO20024844D0 (no) Fremgangsmåte for fremstilling av börstehår for påföring av medier, börstehår fremstilt med fremgangsmåte og börstevare medslike börstehår
DE60239398D1 (de) Hydrophile diagnosevorrichtungen zur verwendung beim testen biologischer flüssigkeiten
DE60136356D1 (de) Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
DE10192157D2 (de) Lagerungshilfe zur tomographischen Funktionsuntersuchung der Lendenwirbelsäule
EP1634960A4 (de) Sonden zur analyse der wechselwirkung zwischen proteinen und verfahren zur analyse der wechselwirkung zwischen proteinen damit
ATE423573T1 (de) Azithromycin enthaltende stabilisierte suspensionen zur oralen anwendung
DE60321248D1 (de) Verwendung von pollen-isolierten proteinen zur inhibierung der aktivität des anthrax-toxins
Ildikó Analysis of bacterial proteins by capillary electrophoresis
DE10291657D2 (de) Verfahren zur Untersuchung fliessfähiger Medien auf mikrobielle Toxine
ZA200208700B (en) Method and probes for the genetic diagnosis of hemo-chromatosis.
AU2001228324A1 (en) Biological microsensor
SI1610820T1 (sl) Visokokoncentrirane formulacije protitelesa in proteinov
SE0300293D0 (sv) Novel sequence information and methods for its use in diagnosis and therapy XXV
IT1315328B1 (it) Filtro biologico per acquari
GB0003725D0 (en) Virulence gene and protein and their use
GB0023059D0 (en) Virulence gene and protein and their use
GB0002563D0 (en) Virulence gene and protein and their use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition